Hayden E. Klein

Researchers found no evidence of increased risk for severe COVID-19 among children receiving biologic therapies for their psoriasis.

Researchers found that risk of adverse events and mortality did not increase following certain rheumatoid arthritis (RA) treatments.

Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, talks about how dermatologists are working with artificial intelligence (AI) while still making sure patient voices are heard.

Preethi Venkat, MD, second-year internal medicine resident at the University of California, San Diego, discusses differences in hospitalizations for patients with irritable bowel disease (IBD) and Clostridioides difficile (C diff) infection vs those with IBD hospitalized for other reasons.

Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses a session on gastrointestinal (GI) invention at the recent conference, Digestive Disease Week, held May 21-24 in San Diego, California.

Christopher Thompson, MD, MSc, FASGE, FACG, AGAF, FJGES, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, professor of medicine at Harvard Medical School, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.

Individuals with refractory or unexplained chronic cough had characteristics consistent of those with chronic cough in general, including cough duration, severity, and 24-hour frequency.

Snoring affects not only the person who is snoring, but their partners as well, said Michael Johnson, CEO of Rhinomed.

We need more educational or clinical projects that have a real-world impact on reducing disparities in dermatology, said Art Papier, MD, dermatologist, CEO, VisualDx.

It is important that we learn how to exploit DNA damage repair deficiencies to treat cancer help patients in control their disease. explained Hatem Soliman, MD, medical director, Clinical Trials Office, Moffitt Cancer Center.

Using data from a wearable fertility tracking device, researchers developed an algorithm that successfully identified 68% of COVID-19 cases before symptom onset.

Based on limited existing evidence, a systematic review found no single dietary factor had a meaningful impact on rheumatic and musculoskeletal disease (RMD) outcomes.

After completing 6 modules in a digital therapeutic for insomnia, most users met criteria for meaningful treatment response and 40% met criteria for remission.

There needs to be an emphasis on how to reduce the cost and burden of real-world evidence studies, said Patricia Deverka, MD, MS, senior researcher and deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

COVID-19 may not be the only respiratory infection that can result in chronic symptoms afterward.

Adults aged 50 and older who walked for exercise were less likely to develop new frequent knee pain and medial joint space narrowing.

A digital health intervention delivered via smartphone showed that current anxiety symptoms predicted both current and later depressive symptoms.

Prior miscarriage and antinuclear antibody positivity are independent risk factors associated with adverse pregnancy outcomes among women with rheumatoid arthritis (RA).

The developers of these models said the next step is to determine how to incorporate these patient perspectives into clinical rheumatology practice.

Designing rational spending targets and having small sample sizes are 2 main challenges payers and partners face in the shift toward alternative payment models (APMs), said Ravi B. Parikh, MD, MPP, assistant professor of medical ethics and health policy, assistant professor of medicine, University of Pennsylvania.

Providing insurance coverage for multicancer early detection (MCED) tests is vital to reduce disparities in access, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.

Abstracts presented at EULAR 2022 focused on sex-related differences in inflammatory arthritis (IA) management, including adherence to electronically reporting outcomes and disparities in health care utilization.

Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about innovations in gastroenterology technology.

Many socioeconomic factors, such as neighborhood factors, access to care, and education can influence sleep, explained Cinthya Pena Orbea, MD, assistant professor of medicine, Cleveland Clinic.

Once-nightly sodium oxybate was associated with a statistically significant reduction in cataplexy episodes among patients with narcolepsy, explained Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.

While consumer wearables for sleep are popular, evidence-based guidelines need to be established to interpret data coming from these technologies, said Sean Drummond, PhD, professor of clinical neuroscience, Turner Institute for Brain and Mental Health at Monash University.

Michael Johnson, CEO of Rhinomed, expands on the findings of the 2022 Annual Global Sleep and Snoring Report conducted in February 2022, which found that people are not getting nearly as much sleep as they should.

Behavioral and physiological components of type 1 diabetes and its management can contribute to worsened sleep and health outcomes, which can vary by age, according to Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado.

Opioids have been used for hundreds of years to treat restless leg syndrome (RLS), but there is currently a registry to understand the long-term effectiveness of opioids to treat RLS , said John Winkelman, MD, PhD, medical director, sleep disorders clinical research program, Massachusetts General Hospital.

A smartphone application designed to identify jaundice in newborns was found to have a similar success rate as the most commonly used conventional screening method.